Literature DB >> 28216532

JAPANESE GUIDELINES FOR DIAGNOSIS AND TREATMENT OF URTICARIA.

Takaaki Hiragun1, Michihiro Hide.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28216532     DOI： 10.15036/arerugi.66.23

Source DB:  PubMed          Journal:  Arerugi        ISSN： 0021-4884


× No keyword cloud information.
  3 in total

1.  A Comparative, Three-Arm, Randomized Clinical Trial to Evaluate the Effectiveness and Tolerability of Bilastine vs Fexofenadine vs Levocetirizine at the Standard Dose and Bilastine vs Fexofenadine at Higher Than the Standard Dose (Up-Dosing) vs Levocetirizine and Hydroxyzine (in Combination) in Patients with Chronic Spontaneous Urticaria.

Authors:  Bela Shah; Dhiraj Dhoot; Ankita Choudhary; Neha Jangid; Deval Mistry; Shikha Shah; Shruti Kamat; Hanmant Barkate
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-02-18

2.  Efficacy of switching to bilastine, a histamine H1 receptor antagonist, in patients with chronic spontaneous urticaria (H1-SWITCH): study protocol for a randomized controlled trial.

Authors:  Atsushi Fukunaga; Yoshiko Oda; Ken Washio; Takashi Omori; Yasumasa Kakei; Michihiro Hide; Chikako Nishigori
Journal:  Trials       Date:  2020-01-06       Impact factor: 2.279

3.  Real-Life Experience of Efficacy and Safety of Bilastine in the Refractory Cases of Chronic Spontaneous Urticaria and its Effect on the Quality of Life of Patients.

Authors:  Abhishek De; Kiran Godse; Dhiraj Dhoot; Aarti Sarda
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.